🔗 Share this article Social Media Influencers Fueling Parallel Trade for Unlicensed Weight-Loss Medication A shadow market for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations. Investigational Treatment Gaining Popularity Online Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are urged to message these accounts privately for supplier links, while also obtaining discount codes. Thriving Commerce on Messaging Platforms Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions. Understanding Retatrutide This medication is an experimental injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic. Healthcare Professionals Express Concerns However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of unknown origin. Some professionals stated the popularity for retatrutide could be linked to the rising price of approved slimming treatments such as Mounjaro. Regulatory Status and Implementation Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012. Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, risking penalties, legal action or prison. Service Reaction and Material Elimination According to TikTok, the service has taken down problematic material and banned related keywords and search suggestions. The organization said it was committed to keeping the service secure and investing in enhancing compliance measures. Digital Marketplace Activities Research also found communities with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, populated with photos of slimming results, positive reviews and step-by-step instructions for mixing or administering at home. After moments of joining one community, a vendor shared WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or previous experience. Item Information and Pricing Within these groups, messages show black plastic parcels with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.” Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory responses varying between a several days to “depends on your body”. Platform Moderation and Security Actions A spokesperson for Telegram said it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”. Medical Professional Warnings “People are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U. Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said. Her team has already encountered individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be impure or improperly measured.” Producer Statement A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially serious medical dangers”.